C12N 2710/10364
By serial passage
Official title: by serial passage
C12N2710/10364 (By serial passage) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 7
- Assignees
- 5
- Inventors
- 26
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Single plasmid vector system for packaging recombinant human adenovirus type 4 and application thereof4 Nov 2025US 12,460,227 B2Academy of Military Medical Science, PLA
- Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus30 May 2023US 11,660,337 B2Liaoning Yikang Biological Corporation Limited
- Use of adenoviruses mutated in the VA genes for cancer treatment18 Mar 2008US 7,344,711 B2Oncolytics Biotech Inc.
- Single plasmid vector system for packaging recombinant human adenovirus type 4 and application thereof6 Oct 2022US 2022/0315949 A1Academy of Military Medical Science, PLA
- Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus21 Apr 2022US 2022/0118083 A1Liaoning Yikang Biological Corporation Limited
- Novel vaccine for dog21 Apr 2011US 2011/0091490 A1Nippon Zenyaku Kogyo Co., Ltd.
- Adenoviruses Mutated In The VA Genes For Cancer Treatment3 Mar 2011US 2011/0053249 A1Oncolytics Biotech Inc.
- Adenoviruses mutated in the va genes for cancer treatment13 Aug 2009US 2009/0202489 A2Oncolytics Biotech Inc.
Most cited
By later US patents